Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 7/20 | 1.00 |
| ▸ | MC4R | P32245 | 1/20 | 0.78 |
| ▸ | DRD4 | P21917 | 2/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | POLB | P06746 | 1/20 | 0.75 |
| ▸ | CCR3 | P51677 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | ACHE | P22303 | 1/20 | 0.65 |
| ▸ | PHGDH | O43175 | 1/20 | 0.64 |
| ▸ | MGLL | Q99685 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1415730 | 1.00 | SIGMAR1 (1.00) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL576868 | 1.00 | SIGMAR1 (1.00) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL8188324 | 1.00 | SIGMAR1 (1.00) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL1041303 | 1.00 | SIGMAR1 (1.00) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL242970 | 1.00 | SIGMAR1 (1.00) | SIGMAR1MC4RDRD4LMNAPOLB | |
| Water SCHEMBL8695926 | 0.97 | SIGMAR1 (0.95) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL1044952 | 0.93 | SIGMAR1 (0.86) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL6659339 | 0.93 | SIGMAR1 (0.86) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL576379 | 0.93 | SIGMAR1 (0.86) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL1043563 | 0.93 | SIGMAR1 (0.86) | SIGMAR1MC4RDRD4LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116759632-A | Crown ether lithium salt compound and perovskite lithium battery thereof | 美能能源技术(苏州)有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-115633511-A | Perovskite solar cell and preparation method thereof | 宣城先进光伏技术有限公司 | 2023-01-20 | — | — | CN | claimed |
| US-9312572-B2 | Synergistic additives for electrochemical cells with electrodeposited fuel | FLUIDIC, INC. (US) | 2016-04-12 | — | — | US | claimed |
| US-20140266056-A1 | SYNERGISTIC ADDITIVES FOR ELECTROCHEMICAL CELLS WITH ELECTRODEPOSITED FUEL | FLUIDIC, INC. (US) | 2014-09-18 | — | — | US | claimed |
| WO-2025121238-A1 | METHOD FOR PRODUCING AROMATIC POLYSULFONE | 住友化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| US-20240297344-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-05 | — | — | US | disclosed |
| US-12071395-B2 | Method for producing carbodiimide compound | NISSHINBO CHEMICAL INC. (JP) | 2024-08-27 | — | — | US | disclosed |
| US-12017977-B2 | Method for producing carbodiimide compound | NISSHINBO CHEMICAL INC. (JP) | 2024-06-25 | — | — | US | disclosed |
| US-11935803-B2 | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-03-19 | — | — | US | disclosed |
| CN-116759632-A | Crown ether lithium salt compound and perovskite lithium battery thereof | 美能能源技术(苏州)有限公司 | 2023-09-15 | — | — | CN | disclosed |
| US-20230106672-A1 | METHOD FOR PRODUCING CARBODIIMIDE COMPOUND | NISSHINBO CHEMICAL INC. (JP) | 2023-04-06 | — | — | US | disclosed |
| CN-115911573-A | Nonaqueous electrolyte solution for secondary battery and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2023-04-04 | — | — | CN | disclosed |
| US-6048979-A | CYCLOTETRAMERIZING, CLEAVAGE OF ARYLMETHYL GROUPS TO PREPARE CYCLEN AND DERIVATIVES | NYCOMED SALUTAR, INC. (US) | 2000-04-11 | — | — | US | disclosed |
| EP-0883610-A1 | PROCESS FOR PREPARING 1,4,7,10-TETRAAZACYCLODODECANE AND ITS DERIVATIVES | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-12-16 | — | — | EP | disclosed |
| EP-0872479-A1 | Chelated complexes of paramagnetic metals with low toxicity | BRACCO S.p.A. (IT) | 1998-10-21 | — | — | EP | disclosed |
| US-5744616-A | CYCLOTETRAMERIZATION OF A BENZYLAZIRIDINE DERIVATIVE | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-04-28 | — | — | US | disclosed |
| EP-0813523-A2 | PREPARATION OF N-ARYLMETHYL AZIRIDINE DERIVATIVES, 1,4,7,10-TETRAAZACYCLODODECANE DERIVATIVES OBTAINED THEREFROM AND N-ARYLMETHYL-ETHANOL-AMINE SULPHONATE ESTERS AS INTERMEDIATES | NYCOMED SALUTAR, INC. (US) | 1997-12-29 | — | — | EP | disclosed |
| WO-1997031905-A1 | PROCESS FOR PREPARING 1,4,7,10-TETRAAZACYCLODODECANE AND ITS DERIVATIVES | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-09-04 | — | — | WO | disclosed |
| WO-1996028420-A2 | PREPARATION OF N-ARYLMETHYL AZIRIDINE DERIVATIVES, 1,4,7,10-TETRAAZACYCLODODECANE DERIVATIVES OBTAINED THEREFROM AND N-ARYLMETHYL-ETHANOL-AMINE SULPHONATE ESTERS AS INTERMEDIATES | NYCOMED SALUTAR, INC. (US) | 1996-09-19 | — | — | WO | disclosed |
| EP-0255471-A1 | 1,4,7,10-Tetraazacyclododecane-derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230106672-A1 | METHOD FOR PRODUCING CARBODIIMIDE COMPOUND | CA9, CA4, CA14 | SIGMAR1 4718/4885MC4R 3898/4885DRD4 1578/4885 |
| US-12071395-B2 | Method for producing carbodiimide compound | IDH2, IDH3A, IDH1 | SIGMAR1 4661/4885MC4R 4499/4885DRD4 684/4885 |
| US-12017977-B2 | Method for producing carbodiimide compound | CA9, CA4, CA14 | SIGMAR1 4718/4885MC4R 3898/4885DRD4 1578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.